[關(guān)鍵詞]
[摘要]
慢性乙型肝炎是由乙型肝炎病毒(HBV)引起的一種世界性疾病,近年來,核苷類抗病毒藥物的出現(xiàn)為慢性乙型肝炎的治療開辟了一個(gè)新的領(lǐng)域。對核苷類抗乙肝病毒藥物研究進(jìn)展進(jìn)行綜述,為其進(jìn)一步研究和臨床應(yīng)用提供參考。
[Key word]
[Abstract]
Hepatitis B virus (HBV) is the causative agent of viral hepatitis B, and chronic infection with HBV presents one of the most serious public health challenges worldwide. Recently, nucleoside analogues has been used for the treatment of chronic hepatitis B. This review is about the advance in the research of nucleoside analogues against hepatitis B virus.
[中圖分類號]
[基金項(xiàng)目]
國家自然科學(xué)基金資助項(xiàng)目(30672500);科技部“十一五”科技重大專項(xiàng)(2009ZX09302-002)